An R.S.V. Shot for Infants Is in Short Supply. Here’s What to Know.

Health officials have revised their recommendations on which children should receive the new R.S.V drug. Pediatricians and parents are having difficulty accessing a new immunization used to prevent severe respiratory syncytial virus infections in infants.

The Centers for Disease Control and Prevention initially recommended that it be given to all infants who are less than 8 months old, and to children 8 to 19 months old who have an increased risk for severe R.S.V. The C.D.C issued an alert about the drug’s limited availability and said doctors who currently have doses should prioritize babies who are at the highest risk for infections.

This article appeals to parents. It contains very important information about the availability of vaccinations that their children will need. It also informs parents if their child is a part of the high risk group and has high priority in getting the vaccination.

Click here to view the full article.